search
Back to results

Brain Stimulation for the Treatment of Tourette Syndrome

Primary Purpose

Tourette Syndrome

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
NeuroPace RNS® System Deep Brain Stimulator
Sponsored by
University of Florida
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Tourette Syndrome focused on measuring tourette, tourette's, TS, tourette syndrome, tourette's syndrome

Eligibility Criteria

25 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • diagnosis of TS must be made by both a neurologist and a psychiatrist and must meet standardized criteria
  • must have a minimum score on the primary tic rating scale
  • symptoms must be causing significant impairment in functioning, making it impossible or almost impossible to do daily activities, including work or school and interactions with friends and family, causing severe distress and a poor quality of life
  • symptoms have not responded well enough to medications prescribed by a neurologist or psychiatrist experienced in treating TS. Must have had trials of drugs from three different classes of drugs that have not worked.
  • must have received stable and effective treatment of any other existing medical or psychological problems for the past 6 months.
  • current TS related-medication(s) must be stable for at least a month without a dose change prior to surgery and must be willing to keep these medications stable and unchanged throughout the study or must be off of TS-related medications for at least three months prior to surgery
  • If tics involve only one group of muscles or might be controllable by botulinum toxin treatment, must try botulinum treatment before considering surgery.
  • must have a negative urine drug screen
  • must give informed consent

Exclusion Criteria:

  • have a simple motor tic or movement disorder other than TS, or medication-related movement disorders from TS medications
  • have had any previous brain surgery including deep brain stimulation, ablative capsulotomy or cingulotomy
  • have another psychiatric condition (including body dysmorphic disorder, a delusional disorder or a biological brain disorder), dementia or cognitive dysfunction that would place subject at risk for worsening cognition and/or may impact ability to comply with study procedures. Also included is any other psychiatric disorder that requires medications or treatments that would interfere with the functioning of the DBS device.
  • have any significant substance abuse or dependence (e.g., stimulants, alcohol, opiates, benzodiazepines) within the past six months
  • have a severe medical disease including cardiovascular disorder, lung disorder, kidney disease, chronic neurological disease, hematological disease, or frailty that impacts tolerability of the surgery as judged by the screening physicians
  • pre-surgery MRI is considered abnormal. You may also be excluded if your brain is considered very small.
  • have a history of serious suicidal behavior, are unable to control suicide attempts, or are currently at risk of suicide, in the judgement of the investigator
  • have head-banging tics or tics that have the potential to damage the RNS System
  • are currently pregnant or breast-feeding, plan to become pregnant during the study, or are not using effective contraception
  • are currently enrolled in another investigational study
  • have an implant such as a pacemaker or neurostimulator containing electrical circuitry or that generates electrical signals
  • have any metal orthopedic pins or plates, metal orthodontics, or non-removable body jewelry
  • require diathermy treatments during physical or occupational therapy
  • have a problem that will require repeat Magnetic Resonance Imaging (MRI) scans

Sites / Locations

  • University of Florida Movement Disorders Center

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Delayed Activation - Deep Brain Stimulation (DBS)

Immediate Activation - Deep Brain Stimulation (DBS)

Arm Description

Delayed Activation stimulation in which no electrical charge is delivered through the Neuropace RNS (responsive neurostimulation) system for the first 59 days. On Day 60, all subjects will be programmed to receive active stimulation. There will be a one month post-operative period during which stimulation is not turned on. One month post-implant, subjects will be randomized one to one in a blinded fashion to receive active or sham stimulation. By Day 60, all subjects will be programmed to receive active stimulation. Physiological data will be collected for Specific Aim 2 of the study. Both the sham and the active groups (3 subjects in each group) will undergo identical programming procedures at 30 and 60 days.

Active stimulation through the Neuropace RNS (responsive neurostimulation) system at settings to maximally reduce tic frequency & severity, while limiting potential stimulation-induced side-effects. There will be a one month post-operative period during which stimulation is not turned on. One month post-implant, subjects will be randomized one to one in a blinded fashion to receive active or sham stimulation. By Day 60, all subjects will be programmed to receive active stimulation. Physiological data will be collected for Specific Aim 2 of the study. Both the sham and the active groups (3 subjects in each group) will undergo identical programming procedures at 30 and 60 days.

Outcomes

Primary Outcome Measures

Mean Change in Yale Global Tic Severity Scale (YGTSS) Scores From Baseline to 6 Months Across All Study Participants Presented
The Yale Global Tic Severity Scale (YGTSS) is a semistructured clinician-rated instrument that assesses the severity and frequency of motor and phonic tics over the previous week. Five index scores are obtained during the assessment, where higher scores indicate greater frequency or severity. These indices are: Total Motor Tic Score (0-25) Total Phonic Tic Score (0-25 Total Tic Score (0-50) Overall Impairment Rating (0-50) Global Severity Score (0-7) The YGTSS Total Score is obtained by adding the Total Tic Score to the Overall Impairment Rating. The efficacy of the intervention will be assessed by comparing each subject's 6-month YGTSS Total Score to the pre-operative value for the same patient. Efficacy is considered 50% or greater reduction in this score.

Secondary Outcome Measures

Correlation of Tics and Neural Physiology
Electrical recordings of electroencephalography activity were taken from each subject's implanted leads at each visit from baseline to 6 months. At baseline, the recordings were taken with the device in the off state (not stimulating), while at the 6 month visits the recordings were taken with the subject's device set to optimal parameters for tic control. Using Pearson's correlation coefficient, the variations in frequency and power which were observed were correlated with the Yale Global Tic Severity (YGTSS) scores obtained during primary outcome testing.

Full Information

First Posted
March 25, 2011
Last Updated
June 5, 2018
Sponsor
University of Florida
search

1. Study Identification

Unique Protocol Identification Number
NCT01329198
Brief Title
Brain Stimulation for the Treatment of Tourette Syndrome
Official Title
Scheduled and Responsive Brain Stimulation for the Treatment of Tourette Syndrome
Study Type
Interventional

2. Study Status

Record Verification Date
June 2018
Overall Recruitment Status
Completed
Study Start Date
September 2009 (undefined)
Primary Completion Date
November 2011 (Actual)
Study Completion Date
April 2017 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Florida

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of this trial is to determine whether a particular type of Deep Brain Stimulation (DBS), scheduled Deep Brain stimulation (SBS), is an effective and safe treatment for Tourettte syndrome (TS). The trial will also examine the brain activity associated with TS and tics and explore the possibility of responsive brain stimulation (RBS).
Detailed Description
DBS is a surgical procedure that seeks to change the brain's electrical signalling by means of applied electrical current. To this end, a wire with tiny stimulating electrodes is implanted into one or both sides of the brain. An electrode is a small piece of metal used to take an electric current to or from a power source. These electrodes are connected under the skin on the scalp to a small electrical unit called an INS (implantable neurostimulator), which is similar to a heart pacemaker. The device sends out electrical impulses that appear to change the normal flow of electricity in the brain. The wires which house the electrodes will be implanted on both sides of the brain oriented towards the centromedian thalamus-parafascicular complex. This region of the brain has to date the greats number of documented cases revealing significant improvements in motor tics. This region of the brain will also provide a target where physiological changes related to motor tics are likely to be discovered. The device we propose for this study has several features that make it more suitable for use in the TS population than other devices. It is self-contained in the skull and brain, and contains no tunneled neck connector wire and no chest pacemaker deice. This will help to lessen infection, and will assist in limiting device-related fractures due to tics involving neck region. Also, the system can record electro-encephalograph data from the area of the electrodes, which will assist us in gathering information about what specific physiological changes are correlated with tics.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Tourette Syndrome
Keywords
tourette, tourette's, TS, tourette syndrome, tourette's syndrome

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Prospective blinded staggered onset design
Masking
ParticipantCare ProviderOutcomes Assessor
Masking Description
Programming to be performed for this study by the programming investigator under the supervision of the PI
Allocation
Randomized
Enrollment
5 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Delayed Activation - Deep Brain Stimulation (DBS)
Arm Type
Active Comparator
Arm Description
Delayed Activation stimulation in which no electrical charge is delivered through the Neuropace RNS (responsive neurostimulation) system for the first 59 days. On Day 60, all subjects will be programmed to receive active stimulation. There will be a one month post-operative period during which stimulation is not turned on. One month post-implant, subjects will be randomized one to one in a blinded fashion to receive active or sham stimulation. By Day 60, all subjects will be programmed to receive active stimulation. Physiological data will be collected for Specific Aim 2 of the study. Both the sham and the active groups (3 subjects in each group) will undergo identical programming procedures at 30 and 60 days.
Arm Title
Immediate Activation - Deep Brain Stimulation (DBS)
Arm Type
Active Comparator
Arm Description
Active stimulation through the Neuropace RNS (responsive neurostimulation) system at settings to maximally reduce tic frequency & severity, while limiting potential stimulation-induced side-effects. There will be a one month post-operative period during which stimulation is not turned on. One month post-implant, subjects will be randomized one to one in a blinded fashion to receive active or sham stimulation. By Day 60, all subjects will be programmed to receive active stimulation. Physiological data will be collected for Specific Aim 2 of the study. Both the sham and the active groups (3 subjects in each group) will undergo identical programming procedures at 30 and 60 days.
Intervention Type
Device
Intervention Name(s)
NeuroPace RNS® System Deep Brain Stimulator
Other Intervention Name(s)
NeuroPace DBS (deep brain stimulation)
Intervention Description
Utilizes a signal that the device detects and will respond to with an electrical pre-defined pulse if the signal is encountered.
Primary Outcome Measure Information:
Title
Mean Change in Yale Global Tic Severity Scale (YGTSS) Scores From Baseline to 6 Months Across All Study Participants Presented
Description
The Yale Global Tic Severity Scale (YGTSS) is a semistructured clinician-rated instrument that assesses the severity and frequency of motor and phonic tics over the previous week. Five index scores are obtained during the assessment, where higher scores indicate greater frequency or severity. These indices are: Total Motor Tic Score (0-25) Total Phonic Tic Score (0-25 Total Tic Score (0-50) Overall Impairment Rating (0-50) Global Severity Score (0-7) The YGTSS Total Score is obtained by adding the Total Tic Score to the Overall Impairment Rating. The efficacy of the intervention will be assessed by comparing each subject's 6-month YGTSS Total Score to the pre-operative value for the same patient. Efficacy is considered 50% or greater reduction in this score.
Time Frame
Baseline to 6 Months
Secondary Outcome Measure Information:
Title
Correlation of Tics and Neural Physiology
Description
Electrical recordings of electroencephalography activity were taken from each subject's implanted leads at each visit from baseline to 6 months. At baseline, the recordings were taken with the device in the off state (not stimulating), while at the 6 month visits the recordings were taken with the subject's device set to optimal parameters for tic control. Using Pearson's correlation coefficient, the variations in frequency and power which were observed were correlated with the Yale Global Tic Severity (YGTSS) scores obtained during primary outcome testing.
Time Frame
Baseline to 6 Months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
25 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: diagnosis of TS must be made by both a neurologist and a psychiatrist and must meet standardized criteria must have a minimum score on the primary tic rating scale symptoms must be causing significant impairment in functioning, making it impossible or almost impossible to do daily activities, including work or school and interactions with friends and family, causing severe distress and a poor quality of life symptoms have not responded well enough to medications prescribed by a neurologist or psychiatrist experienced in treating TS. Must have had trials of drugs from three different classes of drugs that have not worked. must have received stable and effective treatment of any other existing medical or psychological problems for the past 6 months. current TS related-medication(s) must be stable for at least a month without a dose change prior to surgery and must be willing to keep these medications stable and unchanged throughout the study or must be off of TS-related medications for at least three months prior to surgery If tics involve only one group of muscles or might be controllable by botulinum toxin treatment, must try botulinum treatment before considering surgery. must have a negative urine drug screen must give informed consent Exclusion Criteria: have a simple motor tic or movement disorder other than TS, or medication-related movement disorders from TS medications have had any previous brain surgery including deep brain stimulation, ablative capsulotomy or cingulotomy have another psychiatric condition (including body dysmorphic disorder, a delusional disorder or a biological brain disorder), dementia or cognitive dysfunction that would place subject at risk for worsening cognition and/or may impact ability to comply with study procedures. Also included is any other psychiatric disorder that requires medications or treatments that would interfere with the functioning of the DBS device. have any significant substance abuse or dependence (e.g., stimulants, alcohol, opiates, benzodiazepines) within the past six months have a severe medical disease including cardiovascular disorder, lung disorder, kidney disease, chronic neurological disease, hematological disease, or frailty that impacts tolerability of the surgery as judged by the screening physicians pre-surgery MRI is considered abnormal. You may also be excluded if your brain is considered very small. have a history of serious suicidal behavior, are unable to control suicide attempts, or are currently at risk of suicide, in the judgement of the investigator have head-banging tics or tics that have the potential to damage the RNS System are currently pregnant or breast-feeding, plan to become pregnant during the study, or are not using effective contraception are currently enrolled in another investigational study have an implant such as a pacemaker or neurostimulator containing electrical circuitry or that generates electrical signals have any metal orthopedic pins or plates, metal orthodontics, or non-removable body jewelry require diathermy treatments during physical or occupational therapy have a problem that will require repeat Magnetic Resonance Imaging (MRI) scans
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Michael Okun, MD
Organizational Affiliation
University of Florida
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Florida Movement Disorders Center
City
Gainesville
State/Province
Florida
ZIP/Postal Code
32611
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
23044532
Citation
Okun MS, Foote KD, Wu SS, Ward HE, Bowers D, Rodriguez RL, Malaty IA, Goodman WK, Gilbert DM, Walker HC, Mink JW, Merritt S, Morishita T, Sanchez JC. A trial of scheduled deep brain stimulation for Tourette syndrome: moving away from continuous deep brain stimulation paradigms. JAMA Neurol. 2013 Jan;70(1):85-94. doi: 10.1001/jamaneurol.2013.580.
Results Reference
derived
Links:
URL
https://jamanetwork.com/journals/jamaneurology/fullarticle/1377557
Description
A Trial of Scheduled Deep Brain Stimulation for Tourette Syndrome
URL
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3435399/
Description
Increased Thalamic Gamma Band Activity Correlates with Symptom Relief following Deep Brain Stimulation in Humans with Tourette's Syndrome

Learn more about this trial

Brain Stimulation for the Treatment of Tourette Syndrome

We'll reach out to this number within 24 hrs